CRISPR Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 3,416 | 0.00402% |
Individual Insiders | 485,977 | 0.573% |
General Public | 30,481,540 | 35.9% |
Institutions | 53,912,158 | 63.5% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 7.6%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
8,157,028 | US$432.2m | -4.44% | 3.39% | |||
6,420,736 | US$340.2m | 0.92% | 0.02% | |||
4,475,532 | US$237.2m | -1.02% | 0.02% | |||
3,268,785 | US$173.2m | -3% | 0.07% | |||
2,516,486 | US$133.3m | -7.25% | no data | |||
1,839,029 | US$97.4m | -10.6% | 0.01% | |||
1,753,497 | US$92.9m | -6.97% | no data | |||
1,590,651 | US$84.3m | 3.37% | no data | |||
1,587,854 | US$84.1m | 0% | 4.59% | |||
1,067,351 | US$56.6m | -2.65% | 0.08% | |||
1,048,951 | US$55.6m | 0% | 16.73% | |||
900,400 | US$47.7m | 0.22% | 0.55% | |||
883,729 | US$46.8m | 3.98% | no data | |||
779,454 | US$41.3m | -11.4% | 0.01% | |||
726,887 | US$38.5m | 0% | 0.15% | |||
699,332 | US$37.1m | -5.79% | 0.03% | |||
653,023 | US$34.6m | 0% | 0.01% | |||
617,586 | US$32.7m | -13.7% | no data | |||
549,007 | US$29.1m | 19.7% | 0.01% | |||
508,100 | US$26.9m | 0% | 0.07% | |||
498,558 | US$26.4m | 0% | 8.38% | |||
475,008 | US$25.2m | 280% | 0.03% | |||
422,763 | US$22.4m | -4.15% | 0.01% | |||
408,122 | US$21.6m | 5.36% | no data | |||
406,855 | US$21.6m | -5.44% | no data |